Cargando…

Peroxisome Proliferator–Activated Receptor-α Agonism With Fenofibrate Does Not Suppress Inflammatory Responses to Evoked Endotoxemia

BACKGROUND: Data conflict with regard to whether peroxisome proliferator–activated receptor-α agonism suppresses inflammation in humans. We hypothesized that in healthy adults peroxisome proliferator–activated receptor-α agonism with fenofibrate would blunt the induced immune responses to endotoxin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulvey, Claire K., Ferguson, Jane F., Tabita-Martinez, Jennifer, Kong, Stephanie, Shah, Rhia Y., Patel, Parth N., Master, Stephen R., Usman, M Haris U., Propert, Kathleen J., Shah, Rachana, Mehta, Nehal N., Reilly, Muredach P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487364/ https://www.ncbi.nlm.nih.gov/pubmed/23130172 http://dx.doi.org/10.1161/JAHA.112.002923

Ejemplares similares

Race and gender variation in response to evoked inflammation
por: Ferguson, Jane F, et al.
Publicado: (2013)

Experimental Endotoxemia Induces Adipose Inflammation and Insulin Resistance in Humans
por: Mehta, Nehal N., et al.
Publicado: (2010)

A human model of inflammatory cardio-metabolic dysfunction; a double blind placebo-controlled crossover trial
por: Mehta, Nehal N, et al.
Publicado: (2012)

Gene Profiling of Human Adipose Tissue During Evoked Inflammation In Vivo
por: Shah, Rachana, et al.
Publicado: (2009)

Differential Associations of Oral Glucose Tolerance Test–Derived Measures of Insulin Sensitivity and Pancreatic β-Cell Function With Coronary Artery Calcification and Microalbuminuria in Type 2 Diabetes
por: Mulvey, Claire K., et al.
Publicado: (2014)

Fractalkine Is a Novel Human Adipochemokine Associated With Type 2 Diabetes
por: Shah, Rachana, et al.
Publicado: (2011)

Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons
por: Tenenbaum, Alexander, et al.
Publicado: (2005)

Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARγ Agonism as Preventive Pharmacological Approach
por: Zanardelli, Matteo, et al.
Publicado: (2014)

Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor α agonist fenofibrate
por: Osada, Miho, et al.
Publicado: (2014)

Expression of Calgranulin Genes S100A8, S100A9 and S100A12 Is Modulated by n-3 PUFA during Inflammation in Adipose Tissue and Mononuclear Cells
por: Shah, Rachana D., et al.
Publicado: (2017)

Key Issues in the Role of Peroxisome Proliferator–Activated Receptor Agonism and Cell Signaling in Trichloroethylene Toxicity
por: Keshava, Nagalakshmi, et al.
Publicado: (2006)

Role of nitric oxide in inflammation and tissue injury during endotoxemia and hemorrhagic shock.
por: Shah, N S, et al.
Publicado: (1998)

Molecular mechanism of agonism and inverse agonism in ghrelin receptor
por: Qin, Jiao, et al.
Publicado: (2022)

Sinapic acid attenuates cisplatin-induced nephrotoxicity through peroxisome proliferator-activated receptor gamma agonism in rats
por: Singh, Hardevinder Pal, et al.
Publicado: (2020)

LPS-Induced Endotoxemia Evokes Epigenetic Alterations in Mitochondrial DNA That Impacts Inflammatory Response
por: Koos, Björn, et al.
Publicado: (2020)

Biased agonism
por: Kenakin, Terry
Publicado: (2009)

Agonizing Hedgehog
por: Weitzman, Jonathan B
Publicado: (2002)

Agon : ballet for twelve dancers
por: Stravinsky, Igor, 1882-1971
Publicado: (1957)

A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations
por: Ling, Hua, et al.
Publicado: (2013)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
por: Syversen, Unni, et al.
Publicado: (2009)

Fenofibrate, a peroxisome proliferator-activated receptor α-agonist, blocks lipopolysaccharide-induced inflammatory pathways in mouse liver
por: Won, Tae Wan
Publicado: (2013)

Obese Mice Lacking Inducible Nitric Oxide Synthase Are Sensitized to the Metabolic Actions of Peroxisome Proliferator–Activated Receptor-γ Agonism
por: Dallaire, Patrice, et al.
Publicado: (2008)

Woman with agonal breathing
por: Hsu, Chien‐Te, et al.
Publicado: (2023)

Rosiglitazone and Fenofibrate Additive Effects on Lipids
por: Slim, Ahmad, et al.
Publicado: (2011)

Fenofibrate decreases radiation sensitivity via peroxisome proliferator-activated receptor α-mediated superoxide dismutase induction in HeLa cells
por: Liu, Xianguang, et al.
Publicado: (2012)

A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy
por: Strain, Joe D, et al.
Publicado: (2010)

Comparison of Efficacy and Safety of Fixed Dose Combination of Rosuvastatin and Choline Fenofibrate to Fixed Dose Combination of Rosuvastatin and Fenofibrate in Patients of Mixed Dyslipidemia: A Randomized, Open-label, Multicentre Clinical Trial in Indian Population
por: Barkate, Hanmant, et al.
Publicado: (2018)

Agonism and Antagonism at the Insulin Receptor
por: Knudsen, Louise, et al.
Publicado: (2012)

Necessity, Entailment, Shared Agonism
por: Smith, Dominic
Publicado: (2021)

Peroxisomal Fitness: A Potential Protective Mechanism of Fenofibrate against High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
por: Jiang, Songling, et al.
Publicado: (2022)

Side Chain Orientation of Tryptophan Analogues Determines Agonism and Inverse Agonism in Short Ghrelin Peptides
por: Nicke, Lennart, et al.
Publicado: (2019)

Fibrane the reduced derivative of fenofibrate
por: Kotheimer, Amanda E., et al.
Publicado: (2019)

A Proteomics-Based Assessment of Inflammation Signatures in Endotoxemia
por: Burnap, Sean A., et al.
Publicado: (2021)

Comparison of efficacy and safety of choline fenofibrate (fenofibric acid) to micronized fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicenter clinical trial in Indian population
por: Patel, Piyush, et al.
Publicado: (2016)

The Peroxisome Proliferator-Activated Receptor (PPAR) α Agonist Fenofibrate Suppresses Chemically Induced Lung Alveolar Proliferative Lesions in Male Obese Hyperlipidemic Mice
por: Kuno, Toshiya, et al.
Publicado: (2014)

The synergistic ameliorative activity of peroxisome proliferator‐activated receptor‐alpha and gamma agonists, fenofibrate and pioglitazone, on hippocampal neurodegeneration in a rat model of insulin resistance
por: Idowu, Olumayowa K., et al.
Publicado: (2022)

Fenofibrate in Primary Biliary Cirrhosis: A Pilot Study
por: Liberopoulos, E.N, et al.
Publicado: (2010)

Hyperinflammation, T cells, and endotoxemia
por: Inoue, Makoto, et al.
Publicado: (2015)

Metabolic Effects of CX3CR1 Deficiency in Diet-Induced Obese Mice
por: Shah, Rachana, et al.
Publicado: (2015)

A Pharmacological Primer of Biased Agonism
por: Andresen, Bradley T
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_d140ej6320t1d1f3ht5ttsdhmk